MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

No pathogenic mutations in HPCA in Chinese dystonia patients

J. Ma, Y.M Liu (Jinan, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 136

Keywords: Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To explore the frequency and spectrum of HPCA mutation in Chinese subjects with dystonia.

Background: Dystonia is known as a group of clinically and etiologically heterogeneous disorders. Genetically defective components play an important role in the genesis of dystonia. Recently, Charlesworth et al. identified HPCA gene was one of the underlying genetic causes of autosomal-recessively inherited dystonia in two unrelated families.

Method: Mutation screening of HPCA were performed in a cohort of Chinese patients with dystonia.

Results: A total of 185 unrelated Chinese Han patients diagnosed with dystonia were recruited. Among these patients, 132 had focal dystonia, 39 had segmental dystonia, 2 had multifocal dystonia and 12 had generalized dystonia. The age at onset was known in 149 patients (80.5%) with average of 29.6 ± 15.2 years. In this cohort, no pathogenic mutations in HPCA were detected. Four heterozygous synonymous missense mutations in HPCA were identified, including c.G264A, c.G297A, c.G411A and c.G566C.

Conclusion: Mutations in HPCA gene may not be a common cause of dystonia in the Chinese population.

To cite this abstract in AMA style:

J. Ma, Y.M Liu. No pathogenic mutations in HPCA in Chinese dystonia patients [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/no-pathogenic-mutations-in-hpca-in-chinese-dystonia-patients/. Accessed May 24, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/no-pathogenic-mutations-in-hpca-in-chinese-dystonia-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley